Daniel is an associate in the firm’s Corporate Department.
Adv. Daniel Kleinman provides legal counsel to a variety of fledgling corporations during their routine business activities and throughout all stages of mergers and acquisitions and other commercial transactions.
Daniel is experienced in advising on corporate law matters and in drawing up a wide range of commercial agreements, including purchase agreements, investment agreements, founders’ agreements, shareholders’ agreements, service agreements, distribution agreements, and more.
In addition, Daniel has experience providing legal services and counsel to third-sector organizations (amutot and public benefit companies) in relation to the corporate and regulatory aspects of those organizations and in relation to their routine activities. This includes drafting donation agreements, assisting in obtaining certificates of proper management, and aiding in obtaining official recognition as a public institution from the Israel Tax Authority.
Interdisciplinary Center Herzliya (LL.B., BA in Business Administration) 2015
Member of Israel Bar Association since 2016
Insights & News - Daniel Kleinman:
Amutot and PBCs Set to Independently Update Details and Information
The Israeli website “GuideStar,” which provides information about Amutot (One of the common types of non-profit organizations in Israel) and PBCs, launched a new and important interface that enables these organizations to independently update their details and information.
Danel Acquires Additional 10% of Enaim Medical Center
The NIS 43 million acquisition will make Danel the owner of 61% of Enaim Medical Center. Advs. Ilan Blumenfeld and Daniel Kleinman represented Danel in the transaction.
Representing Danel Group in Completion of Acquisition of Manor Medical
Advs. Micky Barnea, Ilan Blumenfeld, and Daniel Kleinman from our firm represented Danel Group in the acquisition of Manor Medical, which operates in the surrogacy, egg donation, and medical tourism fields. This transaction constitutes the completion of Danel’s acquisition of Manor Medical based on a NIS 100 million valuation.